SCHEMBL5729311

SCHEMBL5729311

COC(=O)[C@H](CSc1ccc(C(=O)O)cc1N)NC(=O)OC(C)(C)C

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GSTP1 P09211 1/20 0.52
GSTM2 P28161 1/20 0.52
PPARG P37231 9/20 0.45
PPARA Q07869 9/20 0.45
PPARD Q03181 2/20 0.45
ALDH1A1 P00352 4/20 0.43
MAPT P10636 3/20 0.43
NFKB1 P19838 2/20 0.42
NFKB2 Q00653 2/20 0.42
RELA Q04206 2/20 0.42
KLK5 Q9Y337 1/20 0.41
ACE P12821 1/20 0.39
AAK1 Q2M2I8 1/20 0.39
KDM4E B2RXH2 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
GAA P10253 1/20 0.39
PKM P14618 1/20 0.39
HPGD P15428 1/20 0.39
ALOX12 P18054 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5729613 0.92 PPARA (0.53) GSTP1GSTM2PPARGPPARAPPARD
SCHEMBL5729755 0.92 PPARA (0.53) GSTP1GSTM2PPARGPPARAPPARD
SCHEMBL5969493 0.92 PPARA (0.53) GSTP1GSTM2PPARGPPARAPPARD
SCHEMBL28630326 0.86 PPARA (0.51) GSTP1GSTM2PPARGPPARAPPARD
SCHEMBL20280001 0.86 PPARA (0.51) GSTP1GSTM2PPARGPPARAPPARD
SCHEMBL5969038 0.86 GSTP1 (0.52) GSTP1GSTM2ALDH1A1MAPTNFKB1
SCHEMBL5729874 0.86 GSTP1 (0.52) GSTP1GSTM2ALDH1A1MAPTNFKB1
SCHEMBL5728927 0.86 GSTP1 (0.52) GSTP1GSTM2ALDH1A1MAPTNFKB1
SCHEMBL5969068 0.85 GSTP1 (0.47) GSTP1GSTM2PPARGPPARAPPARD
SCHEMBL5728890 0.85 GSTP1 (0.47) GSTP1GSTM2PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1434870-B1 ENZYMATIC PROCESS FOR THE PREPARATION OF SUBSTITUTED 2-AMINO-3-(2-AMINO-PHENYLSULFANYL)-PROPIONIC ACID HOFFMANN LA ROCHE (CH) 2006-12-27 EP disclosed
US-7011960-B2 Substituted 2-amino-3-(2-amino-phenylsulfanyl)-propionic acids HOFFMANN-LA ROCHE INC. (US) 2006-03-14 US disclosed
EP-1434870-A1 ENZYMATIC PROCESS FOR THE PREPARATION OF SUBSTITUTED 2-AMINO-3-(2-AMINO-PHENYLSULFANYL)-PROPIONIC ACID F. HOFFMANN-LA ROCHE AG (CH) 2004-07-07 EP disclosed
US-20030119152-A1 Substituted 2-amino-3- (2-amino-phenylsulfanyl) -propionic acids HOFFMANN-LA ROCHE INC. 2003-06-26 US disclosed
WO-2003029477-A1 ENZYMATIC PROCESS FOR THE PREPARATION OF SUBSTITUTED 2-AMINO-3-(2-AMINO-PHENYLSULFANYL)-PROPIONIC ACID F. HOFFMANN-LA ROCHE AG (CH) 2003-04-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030119152-A1 Substituted 2-amino-3- (2-amino-phenylsulfanyl) -propionic acids CCKAR, AGTR1, AGTR2 GSTP1 1257/4885GSTM2 2055/4885PPARG 505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.